Flora Growth Corp. (NASDAQ: FLGC) Stock Competitors & Peer Comparison

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, TAK has a market cap of 65.3B. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while TAK trades at $20.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas TAK's P/E ratio is 14.99. In terms of profitability, FLGC's ROE is -3.03%, compared to TAK's ROE of +0.05%. Regarding short-term risk, FLGC is more volatile compared to TAK. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check TAK's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, TEVA has a market cap of 50.4B. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while TEVA trades at $43.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas TEVA's P/E ratio is 14.75. In terms of profitability, FLGC's ROE is -3.03%, compared to TEVA's ROE of +0.06%. Regarding short-term risk, FLGC is more volatile compared to TEVA. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check TEVA's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, HLN has a market cap of 40.3B. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while HLN trades at $9.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas HLN's P/E ratio is 18.59. In terms of profitability, FLGC's ROE is -3.03%, compared to HLN's ROE of +0.10%. Regarding short-term risk, FLGC is more volatile compared to HLN. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check HLN's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, ZTS has a market cap of 33.5B. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while ZTS trades at $82.57.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas ZTS's P/E ratio is 12.55. In terms of profitability, FLGC's ROE is -3.03%, compared to ZTS's ROE of +0.76%. Regarding short-term risk, FLGC is more volatile compared to ZTS. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check ZTS's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, VTRS has a market cap of 24.1B. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while VTRS trades at $21.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas VTRS's P/E ratio is 8.36. In terms of profitability, FLGC's ROE is -3.03%, compared to VTRS's ROE of -0.04%. Regarding short-term risk, FLGC is more volatile compared to VTRS. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check VTRS's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, ITCI has a market cap of 14B. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while ITCI trades at $131.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas ITCI's P/E ratio is -180.64. In terms of profitability, FLGC's ROE is -3.03%, compared to ITCI's ROE of -0.09%. Regarding short-term risk, FLGC is more volatile compared to ITCI. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check ITCI's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, ELAN has a market cap of 13.2B. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while ELAN trades at $26.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas ELAN's P/E ratio is 24.98. In terms of profitability, FLGC's ROE is -3.03%, compared to ELAN's ROE of -0.02%. Regarding short-term risk, FLGC is more volatile compared to ELAN. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check ELAN's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, RDY has a market cap of 12.4B. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while RDY trades at $14.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas RDY's P/E ratio is 31.57. In terms of profitability, FLGC's ROE is -3.03%, compared to RDY's ROE of +0.07%. Regarding short-term risk, FLGC is more volatile compared to RDY. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check RDY's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, CTLT has a market cap of 11.5B. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while CTLT trades at $63.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas CTLT's P/E ratio is -27.84. In terms of profitability, FLGC's ROE is -3.03%, compared to CTLT's ROE of -0.25%. Regarding short-term risk, FLGC is more volatile compared to CTLT. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check CTLT's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, ALKS has a market cap of 8B. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while ALKS trades at $47.89.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas ALKS's P/E ratio is 50.41. In terms of profitability, FLGC's ROE is -3.03%, compared to ALKS's ROE of -0.00%. Regarding short-term risk, FLGC is more volatile compared to ALKS. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check ALKS's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, AMRX has a market cap of 7.6B. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while AMRX trades at $21.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas AMRX's P/E ratio is 24.12. In terms of profitability, FLGC's ROE is -3.03%, compared to AMRX's ROE of +1.32%. Regarding short-term risk, FLGC is more volatile compared to AMRX. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check AMRX's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, LNTH has a market cap of 6.6B. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while LNTH trades at $101.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas LNTH's P/E ratio is 17.08. In terms of profitability, FLGC's ROE is -3.03%, compared to LNTH's ROE of +0.22%. Regarding short-term risk, FLGC is more volatile compared to LNTH. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check LNTH's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, INDV has a market cap of 4.5B. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while INDV trades at $36.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas INDV's P/E ratio is 9.94. In terms of profitability, FLGC's ROE is -3.03%, compared to INDV's ROE of -3.53%. Regarding short-term risk, FLGC is more volatile compared to INDV. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check INDV's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, BHC has a market cap of 3.1B. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while BHC trades at $8.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas BHC's P/E ratio is 2.13. In terms of profitability, FLGC's ROE is -3.03%, compared to BHC's ROE of +0.59%. Regarding short-term risk, FLGC is more volatile compared to BHC. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check BHC's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, RGC has a market cap of 2.7B. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while RGC trades at $5.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas RGC's P/E ratio is -541.00. In terms of profitability, FLGC's ROE is -3.03%, compared to RGC's ROE of -1.61%. Regarding short-term risk, FLGC is more volatile compared to RGC. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check RGC's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, HCM has a market cap of 2.6B. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while HCM trades at $15.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas HCM's P/E ratio is 145.84. In terms of profitability, FLGC's ROE is -3.03%, compared to HCM's ROE of +0.01%. Regarding short-term risk, FLGC is more volatile compared to HCM. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check HCM's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, PRGO has a market cap of 2.3B. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while PRGO trades at $16.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas PRGO's P/E ratio is 6.62. In terms of profitability, FLGC's ROE is -3.03%, compared to PRGO's ROE of -0.68%. Regarding short-term risk, FLGC is more volatile compared to PRGO. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check PRGO's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, DCPH has a market cap of 2.2B. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while DCPH trades at $25.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas DCPH's P/E ratio is -11.58. In terms of profitability, FLGC's ROE is -3.03%, compared to DCPH's ROE of -0.56%. Regarding short-term risk, FLGC is more volatile compared to DCPH. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check DCPH's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, AVDL has a market cap of 2.1B. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while AVDL trades at $21.64.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas AVDL's P/E ratio is -1082.00. In terms of profitability, FLGC's ROE is -3.03%, compared to AVDL's ROE of +0.10%. Regarding short-term risk, FLGC is more volatile compared to AVDL. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check AVDL's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, ETON has a market cap of 2B. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while ETON trades at $68.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas ETON's P/E ratio is 180.00. In terms of profitability, FLGC's ROE is -3.03%, compared to ETON's ROE of +1.05%. Regarding short-term risk, FLGC is more volatile compared to ETON. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check ETON's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, TRLV has a market cap of 1.9B. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while TRLV trades at $11.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas TRLV's P/E ratio is -4.57. In terms of profitability, FLGC's ROE is -3.03%, compared to TRLV's ROE of -0.46%. Regarding short-term risk, FLGC is more volatile compared to TRLV. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check TRLV's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, EMBCV has a market cap of 1.9B. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while EMBCV trades at $33.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas EMBCV's P/E ratio is N/A. In terms of profitability, FLGC's ROE is -3.03%, compared to EMBCV's ROE of -0.19%. Regarding short-term risk, FLGC is more volatile compared to EMBCV. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check EMBCV's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, DVAX has a market cap of 1.8B. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while DVAX trades at $15.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas DVAX's P/E ratio is -41.89. In terms of profitability, FLGC's ROE is -3.03%, compared to DVAX's ROE of +0.09%. Regarding short-term risk, FLGC is more volatile compared to DVAX. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check DVAX's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, ALVO has a market cap of 1.8B. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while ALVO trades at $4.92.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas ALVO's P/E ratio is -8.34. In terms of profitability, FLGC's ROE is -3.03%, compared to ALVO's ROE of +0.77%. Regarding short-term risk, FLGC is more volatile compared to ALVO. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check ALVO's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, SUPN has a market cap of 1.7B. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while SUPN trades at $29.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas SUPN's P/E ratio is -38.89. In terms of profitability, FLGC's ROE is -3.03%, compared to SUPN's ROE of -3.53%. Regarding short-term risk, FLGC is more volatile compared to SUPN. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check SUPN's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, ALVOW has a market cap of 1.7B. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while ALVOW trades at $0.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas ALVOW's P/E ratio is 26.59. In terms of profitability, FLGC's ROE is -3.03%, compared to ALVOW's ROE of +0.77%. Regarding short-term risk, FLGC is more volatile compared to ALVOW. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check ALVOW's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, ANIP has a market cap of 1.6B. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while ANIP trades at $71.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas ANIP's P/E ratio is 8.65. In terms of profitability, FLGC's ROE is -3.03%, compared to ANIP's ROE of +0.20%. Regarding short-term risk, FLGC is more volatile compared to ANIP. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check ANIP's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, TARO has a market cap of 1.6B. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while TARO trades at $42.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas TARO's P/E ratio is 30.05. In terms of profitability, FLGC's ROE is -3.03%, compared to TARO's ROE of +0.03%. Regarding short-term risk, FLGC is more volatile compared to TARO. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check TARO's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, PCRX has a market cap of 1.5B. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while PCRX trades at $36.46.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas PCRX's P/E ratio is 14.02. In terms of profitability, FLGC's ROE is -3.03%, compared to PCRX's ROE of +0.06%. Regarding short-term risk, FLGC is more volatile compared to PCRX. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check PCRX's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, PAHC has a market cap of 1.4B. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while PAHC trades at $35.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas PAHC's P/E ratio is 12.00. In terms of profitability, FLGC's ROE is -3.03%, compared to PAHC's ROE of +0.27%. Regarding short-term risk, FLGC is more volatile compared to PAHC. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check PAHC's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, CRON has a market cap of 1.3B. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while CRON trades at $3.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas CRON's P/E ratio is 17.67. In terms of profitability, FLGC's ROE is -3.03%, compared to CRON's ROE of +0.05%. Regarding short-term risk, FLGC is more volatile compared to CRON. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check CRON's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, AMPH has a market cap of 1.2B. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while AMPH trades at $28.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas AMPH's P/E ratio is 9.76. In terms of profitability, FLGC's ROE is -3.03%, compared to AMPH's ROE of +0.13%. Regarding short-term risk, FLGC is more volatile compared to AMPH. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check AMPH's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, HROW has a market cap of 1.1B. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while HROW trades at $29.37.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas HROW's P/E ratio is -29.67. In terms of profitability, FLGC's ROE is -3.03%, compared to HROW's ROE of -0.91%. Regarding short-term risk, FLGC is more volatile compared to HROW. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check HROW's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, PETQ has a market cap of 919.2M. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while PETQ trades at $30.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas PETQ's P/E ratio is 83.73. In terms of profitability, FLGC's ROE is -3.03%, compared to PETQ's ROE of +0.01%. Regarding short-term risk, FLGC is more volatile compared to PETQ. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check PETQ's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, IRWD has a market cap of 806.2M. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while IRWD trades at $4.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas IRWD's P/E ratio is 6.24. In terms of profitability, FLGC's ROE is -3.03%, compared to IRWD's ROE of -0.81%. Regarding short-term risk, FLGC is more volatile compared to IRWD. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check IRWD's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, COLL has a market cap of 771M. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while COLL trades at $24.81.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas COLL's P/E ratio is 3.11. In terms of profitability, FLGC's ROE is -3.03%, compared to COLL's ROE of +0.12%. Regarding short-term risk, FLGC is more volatile compared to COLL. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check COLL's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, EVO has a market cap of 600.3M. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while EVO trades at $1.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas EVO's P/E ratio is -2.39. In terms of profitability, FLGC's ROE is -3.03%, compared to EVO's ROE of -0.26%. Regarding short-term risk, FLGC is more volatile compared to EVO. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check EVO's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, BDSI has a market cap of 577.1M. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while BDSI trades at $5.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas BDSI's P/E ratio is 6.82. In terms of profitability, FLGC's ROE is -3.03%, compared to BDSI's ROE of +0.57%. Regarding short-term risk, FLGC is more volatile compared to BDSI. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check BDSI's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, TKNO has a market cap of 541M. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while TKNO trades at $8.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas TKNO's P/E ratio is -27.81. In terms of profitability, FLGC's ROE is -3.03%, compared to TKNO's ROE of -0.25%. Regarding short-term risk, FLGC is more volatile compared to TKNO. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check TKNO's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, EOLS has a market cap of 491.1M. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while EOLS trades at $7.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas EOLS's P/E ratio is -23.50. In terms of profitability, FLGC's ROE is -3.03%, compared to EOLS's ROE of +1.03%. Regarding short-term risk, FLGC is more volatile compared to EOLS. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check EOLS's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, KMDA has a market cap of 469.1M. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while KMDA trades at $8.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas KMDA's P/E ratio is 21.39. In terms of profitability, FLGC's ROE is -3.03%, compared to KMDA's ROE of +0.09%. Regarding short-term risk, FLGC is more volatile compared to KMDA. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check KMDA's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, AQST has a market cap of 450M. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while AQST trades at $3.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas AQST's P/E ratio is -5.51. In terms of profitability, FLGC's ROE is -3.03%, compared to AQST's ROE of +2.55%. Regarding short-term risk, FLGC is more volatile compared to AQST. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check AQST's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, ACB has a market cap of 332M. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while ACB trades at $5.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas ACB's P/E ratio is -3.65. In terms of profitability, FLGC's ROE is -3.03%, compared to ACB's ROE of -0.15%. Regarding short-term risk, FLGC is more volatile compared to ACB. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check ACB's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, EBS has a market cap of 310.5M. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while EBS trades at $6.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas EBS's P/E ratio is 4.19. In terms of profitability, FLGC's ROE is -3.03%, compared to EBS's ROE of -0.61%. Regarding short-term risk, FLGC is more volatile compared to EBS. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check EBS's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, ALIM has a market cap of 301.3M. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while ALIM trades at $5.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas ALIM's P/E ratio is 5.28. In terms of profitability, FLGC's ROE is -3.03%, compared to ALIM's ROE of -1.59%. Regarding short-term risk, FLGC is more volatile compared to ALIM. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check ALIM's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, TLRY has a market cap of 291.9M. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while TLRY trades at $2.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas TLRY's P/E ratio is -1.86. In terms of profitability, FLGC's ROE is -3.03%, compared to TLRY's ROE of -0.10%. Regarding short-term risk, FLGC is more volatile compared to TLRY. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check TLRY's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, LNDC has a market cap of 263.6M. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while LNDC trades at $8.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas LNDC's P/E ratio is -4.04. In terms of profitability, FLGC's ROE is -3.03%, compared to LNDC's ROE of +5.75%. Regarding short-term risk, FLGC is more volatile compared to LNDC. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check LNDC's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, CGC has a market cap of 256.1M. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while CGC trades at $0.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas CGC's P/E ratio is -1.35. In terms of profitability, FLGC's ROE is -3.03%, compared to CGC's ROE of -0.37%. Regarding short-term risk, FLGC is more volatile compared to CGC. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check CGC's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, LFCR has a market cap of 242.6M. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while LFCR trades at $6.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas LFCR's P/E ratio is -5.04. In terms of profitability, FLGC's ROE is -3.03%, compared to LFCR's ROE of +3.82%. Regarding short-term risk, FLGC is more volatile compared to LFCR. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check LFCR's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, TYHT has a market cap of 229.2M. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while TYHT trades at $11.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas TYHT's P/E ratio is -1.61. In terms of profitability, FLGC's ROE is -3.03%, compared to TYHT's ROE of -0.57%. Regarding short-term risk, FLGC is more volatile compared to TYHT. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check TYHT's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, SIGA has a market cap of 225.6M. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while SIGA trades at $3.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas SIGA's P/E ratio is 11.63. In terms of profitability, FLGC's ROE is -3.03%, compared to SIGA's ROE of -0.20%. Regarding short-term risk, FLGC is more volatile compared to SIGA. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check SIGA's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, REPH has a market cap of 177.4M. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while REPH trades at $2.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas REPH's P/E ratio is -8.04. In terms of profitability, FLGC's ROE is -3.03%, compared to REPH's ROE of -0.22%. Regarding short-term risk, FLGC is more volatile compared to REPH. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check REPH's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, GLAS has a market cap of 166.8M. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while GLAS trades at $1.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas GLAS's P/E ratio is -3.39. In terms of profitability, FLGC's ROE is -3.03%, compared to GLAS's ROE of -0.51%. Regarding short-term risk, FLGC is more volatile compared to GLAS. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check GLAS's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, THTX has a market cap of 155.9M. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while THTX trades at $3.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas THTX's P/E ratio is -28.83. In terms of profitability, FLGC's ROE is -3.03%, compared to THTX's ROE of +0.36%. Regarding short-term risk, FLGC is more volatile compared to THTX. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check THTX's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, ASRT has a market cap of 151.9M. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while ASRT trades at $23.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas ASRT's P/E ratio is -7.10. In terms of profitability, FLGC's ROE is -3.03%, compared to ASRT's ROE of -0.39%. Regarding short-term risk, FLGC is more volatile compared to ASRT. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check ASRT's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, ORGO has a market cap of 136.3M. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while ORGO trades at $1.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas ORGO's P/E ratio is 35.00. In terms of profitability, FLGC's ROE is -3.03%, compared to ORGO's ROE of -0.47%. Regarding short-term risk, FLGC is more volatile compared to ORGO. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check ORGO's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, DERM has a market cap of 125.3M. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while DERM trades at $4.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas DERM's P/E ratio is -20.18. In terms of profitability, FLGC's ROE is -3.03%, compared to DERM's ROE of -0.20%. Regarding short-term risk, FLGC is more volatile compared to DERM. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check DERM's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, CRDL has a market cap of 121.9M. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while CRDL trades at $1.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas CRDL's P/E ratio is -4.02. In terms of profitability, FLGC's ROE is -3.03%, compared to CRDL's ROE of -1.94%. Regarding short-term risk, FLGC is more volatile compared to CRDL. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check CRDL's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, OGI has a market cap of 120.4M. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while OGI trades at $0.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas OGI's P/E ratio is 1.92. In terms of profitability, FLGC's ROE is -3.03%, compared to OGI's ROE of +0.21%. Regarding short-term risk, FLGC is more volatile compared to OGI. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check OGI's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, SCTL has a market cap of 116.1M. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while SCTL trades at $1.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas SCTL's P/E ratio is -7.86. In terms of profitability, FLGC's ROE is -3.03%, compared to SCTL's ROE of -0.22%. Regarding short-term risk, FLGC is more volatile compared to SCTL. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check SCTL's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, BGM has a market cap of 110.4M. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while BGM trades at $8.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas BGM's P/E ratio is -1.81. In terms of profitability, FLGC's ROE is -3.03%, compared to BGM's ROE of -0.05%. Regarding short-term risk, FLGC is more volatile compared to BGM. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check BGM's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, PROC has a market cap of 102.1M. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while PROC trades at $1.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas PROC's P/E ratio is 1.53. In terms of profitability, FLGC's ROE is -3.03%, compared to PROC's ROE of -2.22%. Regarding short-term risk, FLGC is more volatile compared to PROC. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check PROC's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, OPTN has a market cap of 97.2M. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while OPTN trades at $9.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas OPTN's P/E ratio is -4.42. In terms of profitability, FLGC's ROE is -3.03%, compared to OPTN's ROE of +0.34%. Regarding short-term risk, FLGC is more volatile compared to OPTN. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check OPTN's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, ZOM has a market cap of 95.3M. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while ZOM trades at $0.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas ZOM's P/E ratio is -1.62. In terms of profitability, FLGC's ROE is -3.03%, compared to ZOM's ROE of -0.14%. Regarding short-term risk, FLGC is more volatile compared to ZOM. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check ZOM's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, CPIX has a market cap of 91.7M. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while CPIX trades at $6.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas CPIX's P/E ratio is -15.30. In terms of profitability, FLGC's ROE is -3.03%, compared to CPIX's ROE of -0.47%. Regarding short-term risk, FLGC is more volatile compared to CPIX. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check CPIX's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, GRVI has a market cap of 88.9M. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while GRVI trades at $4.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas GRVI's P/E ratio is 26.05. In terms of profitability, FLGC's ROE is -3.03%, compared to GRVI's ROE of -4.51%. Regarding short-term risk, FLGC is more volatile compared to GRVI. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check GRVI's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, ZYBT has a market cap of 71.6M. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while ZYBT trades at $1.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas ZYBT's P/E ratio is -7.55. In terms of profitability, FLGC's ROE is -3.03%, compared to ZYBT's ROE of -0.31%. Regarding short-term risk, FLGC is more volatile compared to ZYBT. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check ZYBT's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, ZYNE has a market cap of 70.1M. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while ZYNE trades at $1.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas ZYNE's P/E ratio is -1.65. In terms of profitability, FLGC's ROE is -3.03%, compared to ZYNE's ROE of -0.59%. Regarding short-term risk, FLGC is more volatile compared to ZYNE. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check ZYNE's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, SSIC has a market cap of 66.7M. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while SSIC trades at $10.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas SSIC's P/E ratio is 11.93. In terms of profitability, FLGC's ROE is -3.03%, compared to SSIC's ROE of +0.00%. Regarding short-term risk, FLGC is more volatile compared to SSIC. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check SSIC's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, VLNS has a market cap of 61.5M. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while VLNS trades at $0.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas VLNS's P/E ratio is -1.03. In terms of profitability, FLGC's ROE is -3.03%, compared to VLNS's ROE of N/A. Regarding short-term risk, FLGC is more volatile compared to VLNS. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check VLNS's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, DRRX has a market cap of 59.3M. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while DRRX trades at $1.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas DRRX's P/E ratio is -4.44. In terms of profitability, FLGC's ROE is -3.03%, compared to DRRX's ROE of -0.70%. Regarding short-term risk, FLGC is more volatile compared to DRRX. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check DRRX's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, TLPH has a market cap of 54.5M. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while TLPH trades at $1.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas TLPH's P/E ratio is -3.89. In terms of profitability, FLGC's ROE is -3.03%, compared to TLPH's ROE of -0.87%. Regarding short-term risk, FLGC is more volatile compared to TLPH. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check TLPH's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, INCR has a market cap of 51.2M. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while INCR trades at $3.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas INCR's P/E ratio is -4.16. In terms of profitability, FLGC's ROE is -3.03%, compared to INCR's ROE of -0.09%. Regarding short-term risk, FLGC is more volatile compared to INCR. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check INCR's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, JUPW has a market cap of 49.3M. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while JUPW trades at $1.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas JUPW's P/E ratio is -2.41. In terms of profitability, FLGC's ROE is -3.03%, compared to JUPW's ROE of -3.04%. Regarding short-term risk, FLGC is more volatile compared to JUPW. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check JUPW's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, QLI has a market cap of 38.7M. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while QLI trades at $5.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas QLI's P/E ratio is -4.92. In terms of profitability, FLGC's ROE is -3.03%, compared to QLI's ROE of -0.16%. Regarding short-term risk, FLGC is more volatile compared to QLI. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check QLI's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, HEXO has a market cap of 31.2M. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while HEXO trades at $0.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas HEXO's P/E ratio is -0.26. In terms of profitability, FLGC's ROE is -3.03%, compared to HEXO's ROE of -2.06%. Regarding short-term risk, FLGC is more volatile compared to HEXO. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check HEXO's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, RMTI has a market cap of 28.5M. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while RMTI trades at $7.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas RMTI's P/E ratio is -5.28. In terms of profitability, FLGC's ROE is -3.03%, compared to RMTI's ROE of -0.14%. Regarding short-term risk, FLGC is more volatile compared to RMTI. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check RMTI's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, SHPH has a market cap of 25M. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while SHPH trades at $5.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas SHPH's P/E ratio is -0.24. In terms of profitability, FLGC's ROE is -3.03%, compared to SHPH's ROE of -1.57%. Regarding short-term risk, FLGC is more volatile compared to SHPH. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check SHPH's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, CYTH has a market cap of 23.6M. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while CYTH trades at $0.72.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas CYTH's P/E ratio is -0.80. In terms of profitability, FLGC's ROE is -3.03%, compared to CYTH's ROE of -7.30%. Regarding short-term risk, FLGC is more volatile compared to CYTH. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check CYTH's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, CPHI has a market cap of 22.7M. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while CPHI trades at $0.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas CPHI's P/E ratio is -1.23. In terms of profitability, FLGC's ROE is -3.03%, compared to CPHI's ROE of -0.17%. Regarding short-term risk, FLGC is more volatile compared to CPHI. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check CPHI's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, TXMD has a market cap of 20.8M. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while TXMD trades at $1.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas TXMD's P/E ratio is 91.70. In terms of profitability, FLGC's ROE is -3.03%, compared to TXMD's ROE of -0.01%. Regarding short-term risk, FLGC is more volatile compared to TXMD. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check TXMD's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, AYTU has a market cap of 20M. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while AYTU trades at $1.81.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas AYTU's P/E ratio is -1.56. In terms of profitability, FLGC's ROE is -3.03%, compared to AYTU's ROE of -0.53%. Regarding short-term risk, FLGC is more volatile compared to AYTU. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check AYTU's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, EVOK has a market cap of 18.9M. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while EVOK trades at $11.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas EVOK's P/E ratio is -7.97. In terms of profitability, FLGC's ROE is -3.03%, compared to EVOK's ROE of -0.70%. Regarding short-term risk, FLGC is more volatile compared to EVOK. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check EVOK's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, ACRX has a market cap of 14.6M. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while ACRX trades at $0.86.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas ACRX's P/E ratio is -0.31. In terms of profitability, FLGC's ROE is -3.03%, compared to ACRX's ROE of -0.87%. Regarding short-term risk, FLGC is more volatile compared to ACRX. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check ACRX's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, OPTH has a market cap of 13.7M. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while OPTH trades at $2.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas OPTH's P/E ratio is -1.54. In terms of profitability, FLGC's ROE is -3.03%, compared to OPTH's ROE of -0.90%. Regarding short-term risk, FLGC is more volatile compared to OPTH. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check OPTH's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, AGRX has a market cap of 10.4M. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while AGRX trades at $1.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas AGRX's P/E ratio is -0.89. In terms of profitability, FLGC's ROE is -3.03%, compared to AGRX's ROE of +1.32%. Regarding short-term risk, FLGC is more volatile compared to AGRX. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check AGRX's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, CABR has a market cap of 8.6M. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while CABR trades at $0.86.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas CABR's P/E ratio is -1.21. In terms of profitability, FLGC's ROE is -3.03%, compared to CABR's ROE of -3.86%. Regarding short-term risk, FLGC is more volatile compared to CABR. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check CABR's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, INM has a market cap of 8.5M. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while INM trades at $15.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas INM's P/E ratio is -5.07. In terms of profitability, FLGC's ROE is -3.03%, compared to INM's ROE of -3.04%. Regarding short-term risk, FLGC is more volatile compared to INM. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check INM's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, NLTX has a market cap of 8.2M. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while NLTX trades at $3.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas NLTX's P/E ratio is -0.28. In terms of profitability, FLGC's ROE is -3.03%, compared to NLTX's ROE of -0.44%. Regarding short-term risk, FLGC is more volatile compared to NLTX. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check NLTX's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, LCI has a market cap of 7.4M. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while LCI trades at $0.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas LCI's P/E ratio is -0.04. In terms of profitability, FLGC's ROE is -3.03%, compared to LCI's ROE of +1.66%. Regarding short-term risk, FLGC is more volatile compared to LCI. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check LCI's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, ADMP has a market cap of 7.3M. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while ADMP trades at $0.78.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas ADMP's P/E ratio is -0.08. In terms of profitability, FLGC's ROE is -3.03%, compared to ADMP's ROE of -2.09%. Regarding short-term risk, FLGC is more volatile compared to ADMP. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check ADMP's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, SNOA has a market cap of 5.9M. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while SNOA trades at $1.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas SNOA's P/E ratio is -1.12. In terms of profitability, FLGC's ROE is -3.03%, compared to SNOA's ROE of -0.54%. Regarding short-term risk, FLGC is more volatile compared to SNOA. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check SNOA's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, SBFM has a market cap of 5.8M. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while SBFM trades at $2.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas SBFM's P/E ratio is -0.45. In terms of profitability, FLGC's ROE is -3.03%, compared to SBFM's ROE of -0.24%. Regarding short-term risk, FLGC is more volatile compared to SBFM. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check SBFM's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, MNK has a market cap of 4.5M. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while MNK trades at $0.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas MNK's P/E ratio is -0.44. In terms of profitability, FLGC's ROE is -3.03%, compared to MNK's ROE of -0.33%. Regarding short-term risk, FLGC is more volatile compared to MNK. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check MNK's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, YCBD has a market cap of 4.4M. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while YCBD trades at $0.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas YCBD's P/E ratio is -0.97. In terms of profitability, FLGC's ROE is -3.03%, compared to YCBD's ROE of -0.34%. Regarding short-term risk, FLGC is more volatile compared to YCBD. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check YCBD's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, SBFMW has a market cap of 4.2M. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while SBFMW trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas SBFMW's P/E ratio is N/A. In terms of profitability, FLGC's ROE is -3.03%, compared to SBFMW's ROE of -0.24%. Regarding short-term risk, FLGC is more volatile compared to SBFMW. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check SBFMW's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, GELS has a market cap of 3.9M. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while GELS trades at $0.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas GELS's P/E ratio is -0.96. In terms of profitability, FLGC's ROE is -3.03%, compared to GELS's ROE of -0.36%. Regarding short-term risk, FLGC is more volatile compared to GELS. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check GELS's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, PLXP has a market cap of 2.5M. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while PLXP trades at $0.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas PLXP's P/E ratio is -0.22. In terms of profitability, FLGC's ROE is -3.03%, compared to PLXP's ROE of -1.66%. Regarding short-term risk, FLGC is less volatile compared to PLXP. This indicates lower risk in terms of short-term price fluctuations for FLGC.Check PLXP's competition here

Flora Growth Corp. (NASDAQ: FLGC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FLGC stands at 4.2M. In comparison, ATNX has a market cap of 2.3M. Regarding current trading prices, FLGC is priced at $7.79 on the NASDAQ, while ATNX trades at $0.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FLGC currently has a P/E ratio of -0.19, whereas ATNX's P/E ratio is -0.02. In terms of profitability, FLGC's ROE is -3.03%, compared to ATNX's ROE of +0.22%. Regarding short-term risk, FLGC is more volatile compared to ATNX. This indicates higher risk in terms of short-term price fluctuations for FLGC.Check ATNX's competition here